MUFG Securities EMEA plc reduced its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 43.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 160,000 shares of the healthcare conglomerate’s stock after selling 125,000 shares during the period. UnitedHealth Group accounts for approximately 0.8% of MUFG Securities EMEA plc’s investment portfolio, making the stock its 22nd biggest position. MUFG Securities EMEA plc’s holdings in UnitedHealth Group were worth $35,274,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in the stock. Exane Derivatives raised its position in shares of UnitedHealth Group by 15,333.3% in the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after acquiring an additional 460 shares in the last quarter. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group in the 2nd quarter worth about $114,000. Acrospire Investment Management LLC raised its position in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares in the last quarter. Intellectus Partners LLC raised its position in shares of UnitedHealth Group by 18.2% in the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock worth $152,000 after acquiring an additional 126 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC raised its position in shares of UnitedHealth Group by 461.9% in the 3rd quarter. Wealthcare Advisory Partners LLC now owns 826 shares of the healthcare conglomerate’s stock worth $162,000 after acquiring an additional 679 shares in the last quarter. 86.83% of the stock is owned by institutional investors and hedge funds.
Several research analysts have recently weighed in on UNH shares. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, December 27th. Evercore ISI reissued an “outperform” rating and issued a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a research report on Friday, January 12th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective for the company in a research report on Saturday, January 20th. Wells Fargo reissued an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Finally, ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, December 7th. Two research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $245.14.
UnitedHealth Group Inc (UNH) opened at $227.86 on Friday. The stock has a market capitalization of $222,059.28, a PE ratio of 21.28, a price-to-earnings-growth ratio of 1.34 and a beta of 0.74. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. UnitedHealth Group Inc has a 12 month low of $162.74 and a 12 month high of $250.79.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.11 EPS. equities research analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a yield of 1.32%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 28.01%.
In other UnitedHealth Group news, Director Michele J. Hooper sold 10,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the completion of the transaction, the director now owns 37,284 shares in the company, valued at approximately $8,864,643.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 10,400 shares of UnitedHealth Group stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $229.87, for a total value of $2,390,648.00. Following the transaction, the director now owns 1,781,657 shares of the company’s stock, valued at approximately $409,549,494.59. The disclosure for this sale can be found here. Insiders have sold a total of 30,598 shares of company stock valued at $7,280,073 in the last quarter. Company insiders own 0.89% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “MUFG Securities EMEA plc Has $35.27 Million Position in UnitedHealth Group Inc (UNH)” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/03/18/mufg-securities-emea-plc-has-35-27-million-position-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.